Literature DB >> 28553941

Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation.

David T Riglar1,2, Tobias W Giessen1,2, Michael Baym1,3, S Jordan Kerns1,2, Matthew J Niederhuber1,2, Roderick T Bronson4, Jonathan W Kotula1,2, Georg K Gerber5, Jeffrey C Way2, Pamela A Silver1,2.   

Abstract

Bacteria can be engineered to function as diagnostics or therapeutics in the mammalian gut but commercial translation of technologies to accomplish this has been hindered by the susceptibility of synthetic genetic circuits to mutation and unpredictable function during extended gut colonization. Here, we report stable, engineered bacterial strains that maintain their function for 6 months in the mouse gut. We engineered a commensal murine Escherichia coli strain to detect tetrathionate, which is produced during inflammation. Using our engineered diagnostic strain, which retains memory of exposure in the gut for analysis by fecal testing, we detected tetrathionate in both infection-induced and genetic mouse models of inflammation over 6 months. The synthetic genetic circuits in the engineered strain were genetically stable and functioned as intended over time. The durable performance of these strains confirms the potential of engineered bacteria as living diagnostics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28553941      PMCID: PMC5658125          DOI: 10.1038/nbt.3879

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  34 in total

1.  Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium.

Authors:  C Clairmont; K C Lee; J Pike; M Ittensohn; K B Low; J Pawelek; D Bermudes; S M Brecher; D Margitich; J Turnier; Z Li; X Luo; I King; L M Zheng
Journal:  J Infect Dis       Date:  2000-06-05       Impact factor: 5.226

2.  Visualization of evolutionary stability dynamics and competitive fitness of Escherichia coli engineered with randomized multigene circuits.

Authors:  Sean C Sleight; Herbert M Sauro
Journal:  ACS Synth Biol       Date:  2013-09-04       Impact factor: 5.110

3.  Quantifying cellular capacity identifies gene expression designs with reduced burden.

Authors:  Francesca Ceroni; Rhys Algar; Guy-Bart Stan; Tom Ellis
Journal:  Nat Methods       Date:  2015-04-06       Impact factor: 28.547

4.  Programmable bacteria detect and record an environmental signal in the mammalian gut.

Authors:  Jonathan W Kotula; S Jordan Kerns; Lev A Shaket; Layla Siraj; James J Collins; Jeffrey C Way; Pamela A Silver
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

5.  Inflammatory bowel disease--a radical view.

Authors:  N J Simmonds; D S Rampton
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

6.  Rate and molecular spectrum of spontaneous mutations in the bacterium Escherichia coli as determined by whole-genome sequencing.

Authors:  Heewook Lee; Ellen Popodi; Haixu Tang; Patricia L Foster
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-18       Impact factor: 11.205

7.  Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host.

Authors:  Manja Barthel; Siegfried Hapfelmeier; Leticia Quintanilla-Martínez; Marcus Kremer; Manfred Rohde; Michael Hogardt; Klaus Pfeffer; Holger Rüssmann; Wolf-Dietrich Hardt
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

8.  Gut inflammation provides a respiratory electron acceptor for Salmonella.

Authors:  Sebastian E Winter; Parameth Thiennimitr; Maria G Winter; Brian P Butler; Douglas L Huseby; Robert W Crawford; Joseph M Russell; Charles L Bevins; L Garry Adams; Renée M Tsolis; John R Roth; Andreas J Bäumler
Journal:  Nature       Date:  2010-09-23       Impact factor: 49.962

9.  Designing and engineering evolutionary robust genetic circuits.

Authors:  Sean C Sleight; Bryan A Bartley; Jane A Lieviant; Herbert M Sauro
Journal:  J Biol Eng       Date:  2010-11-01       Impact factor: 4.355

10.  Permanent genetic memory with >1-byte capacity.

Authors:  Lei Yang; Alec A K Nielsen; Jesus Fernandez-Rodriguez; Conor J McClune; Michael T Laub; Timothy K Lu; Christopher A Voigt
Journal:  Nat Methods       Date:  2014-10-26       Impact factor: 28.547

View more
  87 in total

1.  Our Microbiome: On the Challenges, Promises, and Hype.

Authors:  Sara Federici; Jotham Suez; Eran Elinav
Journal:  Results Probl Cell Differ       Date:  2020

2.  Tracking of Engineered Bacteria In Vivo Using Nonstandard Amino Acid Incorporation.

Authors:  Pichet Praveschotinunt; Noémie-Manuelle Dorval Courchesne; Ilona den Hartog; Chaochen Lu; Jessica J Kim; Peter Q Nguyen; Neel S Joshi
Journal:  ACS Synth Biol       Date:  2018-06-06       Impact factor: 5.110

3.  Engineered immune cells as highly sensitive cancer diagnostics.

Authors:  Amin Aalipour; Hui-Yen Chuang; Surya Murty; Aloma L D'Souza; Seung-Min Park; Gunsagar S Gulati; Chirag B Patel; Corinne Beinat; Federico Simonetta; Ivana Martinić; Gayatri Gowrishankar; Elise R Robinson; Eamon Aalipour; Zahra Zhian; Sanjiv S Gambhir
Journal:  Nat Biotechnol       Date:  2019-03-18       Impact factor: 54.908

Review 4.  DNA-based memory devices for recording cellular events.

Authors:  Ravi U Sheth; Harris H Wang
Journal:  Nat Rev Genet       Date:  2018-11       Impact factor: 53.242

5.  Engineered Probiotic for the Inhibition of Salmonella via Tetrathionate-Induced Production of Microcin H47.

Authors:  Jacob D Palmer; Emma Piattelli; Beth A McCormick; Mark W Silby; Christopher J Brigham; Vanni Bucci
Journal:  ACS Infect Dis       Date:  2017-09-20       Impact factor: 5.084

Review 6.  Controlling the Implementation of Transgenic Microbes: Are We Ready for What Synthetic Biology Has to Offer?

Authors:  Finn Stirling; Pamela A Silver
Journal:  Mol Cell       Date:  2020-05-21       Impact factor: 17.970

Review 7.  Engineering bacteria for diagnostic and therapeutic applications.

Authors:  David T Riglar; Pamela A Silver
Journal:  Nat Rev Microbiol       Date:  2018-02-05       Impact factor: 60.633

Review 8.  Synthetic biology in probiotic lactic acid bacteria: At the frontier of living therapeutics.

Authors:  Zachary Js Mays; Nikhil U Nair
Journal:  Curr Opin Biotechnol       Date:  2018-03-15       Impact factor: 9.740

9.  On-chip stool liquefaction via acoustofluidics.

Authors:  Shuaiguo Zhao; Weihua He; Zhehan Ma; Peiyao Liu; Po-Hsun Huang; Hunter Bachman; Lin Wang; Shujie Yang; Zhenhua Tian; Zeyu Wang; Yuyang Gu; Zhemiao Xie; Tony Jun Huang
Journal:  Lab Chip       Date:  2019-03-13       Impact factor: 6.799

Review 10.  Understanding and Engineering Distributed Biochemical Pathways in Microbial Communities.

Authors:  Xinyun Cao; Joshua J Hamilton; Ophelia S Venturelli
Journal:  Biochemistry       Date:  2018-11-20       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.